AdvanSix (NYSE: ASIX) is one of 47 publicly-traded companies in the “Specialty Chemicals” industry, but how does it contrast to its competitors? We will compare AdvanSix to related businesses based on the strength of its valuation, dividends, analyst recommendations, institutional ownership, profitability, earnings and risk.

Earnings and Valuation

This table compares AdvanSix and its competitors top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
AdvanSix $1.19 billion $34.14 million 25.29
AdvanSix Competitors $1.91 billion $115.75 million 229.10

AdvanSix’s competitors have higher revenue and earnings than AdvanSix. AdvanSix is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

AdvanSix has a beta of 2.84, meaning that its stock price is 184% more volatile than the S&P 500. Comparatively, AdvanSix’s competitors have a beta of 1.37, meaning that their average stock price is 37% more volatile than the S&P 500.

Insider & Institutional Ownership

71.4% of AdvanSix shares are owned by institutional investors. Comparatively, 65.3% of shares of all “Specialty Chemicals” companies are owned by institutional investors. 2.7% of AdvanSix shares are owned by insiders. Comparatively, 7.4% of shares of all “Specialty Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares AdvanSix and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
AdvanSix 3.64% 20.30% 5.64%
AdvanSix Competitors -639.63% -3.74% 0.56%

Analyst Ratings

This is a summary of current ratings and recommmendations for AdvanSix and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AdvanSix 0 0 1 0 3.00
AdvanSix Competitors 170 1048 1294 24 2.46

AdvanSix presently has a consensus target price of $46.00, indicating a potential upside of 15.12%. As a group, “Specialty Chemicals” companies have a potential upside of 0.76%. Given AdvanSix’s stronger consensus rating and higher possible upside, equities research analysts plainly believe AdvanSix is more favorable than its competitors.

Summary

AdvanSix beats its competitors on 8 of the 13 factors compared.

About AdvanSix

AdvanSix Inc. is an integrated manufacturer of Nylon 6. The Company also sells a variety of other products, all of which are produced as part of the Nylon 6 resin manufacturing process primarily, including caprolactam, ammonium sulfate fertilizers and other chemical intermediates. The Company operates primarily through its integrated manufacturing sites located in Frankford, Pennsylvania, Hopewell, Virginia, and Chesterfield, Virginia. The Company offers ammonium sulfate, which is used by customers as a nitrogen-based fertilizer. It produces ammonium sulfate fertilizer as part of its manufacturing process. The Company manufactures ammonium sulfate fertilizers including Sulf-N and Sulf-N 26. The Company provides AdvanSix Aegis nylon resins and Aegis barrier nylon resins. Its nylon resins are a preferred choice in food, liquid, and consumer packaging along with mono/multifilament products, carpet fibers, automotive compounding and more. It offers Capran biaxially oriented nylon films.

Receive News & Ratings for AdvanSix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix Inc and related companies with MarketBeat.com's FREE daily email newsletter.